Registry Study on Biological Disease Profile and Clinical Outcome in Patients With Newly Diagnosed or Existent Lung Cancer The LuCa Biology and Outcome (BiO)-Project

U

University of Ulm

Status

Enrolling

Conditions

Lung Cancer

Treatments

Other: Registry

Study type

Observational

Funder types

Other

Identifiers

NCT02613637
LuCa BiO

Details and patient eligibility

About

Registry Study on Biological Disease Profile and Clinical Outcome in Patients with Newly Diagnosed or Existent Lung Cancer The LuCa Biology and Outcome (BiO)-Project

Enrollment

2,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with suspected diagnosis of lung cancer, or previously diagnosed lung cancer
  • Age ≥ 18 years. There is no upper age limit.

Exclusion criteria

  • Severe neurological or psychiatric disorder interfering with ability to give an informed consent
  • No consent for registration, storage and processing of the individual disease characteristics and course as well as information of the family physician about study participation
  • No consent for biobanking of patient's biological specimens and performance of analyses on stored material.

Trial contacts and locations

3

Loading...

Central trial contact

Lars Bullinger, MD; Gerlinde Schmidtke-Schrezenmeier, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems